Target 12: By 2025, a comprehensive biosafety system inclusive of a liability and redress regime is operational to manage potential adverse impacts of modern biotechnology on biodiversity and human health.

Malaysia ratified the Cartagena Protocol on Biosafety (CPB) in September 2003 and has immediately taken steps to ensure that a regulatory framework for biosafety is in place to undertake all the other obligations encompassed within the CPB. The Malaysian Biosafety Act 2007 was approved with the main objectives to protect human, plant and animal health, the environment and biological diversity, by regulating the release, importation, exportation and contained use of Living Modified Organisms (LMOs), and the release of products of such organisms. The Act came into force on 1 December 2009. This was followed by the Biosafety (Approval and Notification) Regulations 2010 on 1 November 2010 to implement the Act.